Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tarmac Products is a contract development and manufacturing organization (CDMO) specializing in the formulation and production of semi-solid and liquid dosage forms. The company serves the pharmaceutical, over-the-counter (OTC), and personal care industries, providing services ranging from early-stage formulation development to full-scale commercial manufacturing. Its core expertise lies in the creation of topical products such as creams, gels, ointments, and lotions within an FDA-registered, cGMP-compliant facility. In April 2021, Tarmac Products was acquired by Pace Analytical Services to expand the capabilities of its Pace Life Sciences division. Headquartered in Miami Lakes, Florida, the company continues to operate as a specialized site for topical drug product manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tarmac Products.